Furthermore, Basha and Sankaranarayanan used BCP orally in a dose of 200 mg/kg in streptozotocin-induced diabetic rats for 45 days and found that BCP ameliorated deranged glycoprotein metabolism, decreased hyperglycemia, and mitigated oxidative/inflammatory stress.(31,44) The discrepancy between our data and these studies could be due to the fact that we applied the treatment for a relatively longer duration. This evidence concerns the gene ART4 and Hyperglycemia.